Genetics of Ectopia Lentis

References

• Anteby I, Isaac M, BenEzra D. Hereditary subluxated lenses: visual performances and long-term follow-up after surgery. Ophthalmology 2003;110(7):1344–1348
   PubMedGoogle Scholar
• Rasooly R, Benezra D. Unilateral lens dislocation and axial elongation in Marfan syndrome. Ophthalmic Paediatr Genet 1988;9(2):135–136
   PubMed Web of Science ®Google Scholar
• Callewaert B, Malfait F, Loeys B, De Paepe A. Ehlers-Danlos syndromes and Marfan syndrome. Best Pract Res Clin Rheumatol 2008;22(1):165–189
   PubMed Web of Science ®Google Scholar
• Grahame R, Pyeritz RE. The Marfan syndrome: joint and skin manifestations are prevalent and correlated. Br J Rheumatol 1995;34(2):126–131
   PubMedGoogle Scholar
• Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010;47(7):476–485
   PubMed Web of Science ®Google Scholar
• Maumenee IH. The eye in the Marfan syndrome. Trans Am Ophthalmol Soc 1981;79:684–733
   PubMedGoogle Scholar
• Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989;64(8):507–512
   PubMed Web of Science ®Google Scholar
• Pyeritz RE, Wappel MA. Mitral valve dysfunction in the Marfan syndrome: clinical and echocardiographic study of prevalence and natural history. Am J Med 1983;74(5):797–807
   PubMed Web of Science ®Google Scholar
• Fattori R, Nienaber CA, Descovich B, et al. Importance of dural ectasia in phenotypic assessment of Marfan's syndrome. Lancet 1999;354(9182):910–913
   PubMed Web of Science ®Google Scholar
• Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991;352(6333):337–339
   PubMed Web of Science ®Google Scholar
• Micheal S, Khan MI, Akhtar F, et al. Identification of a novel FBN1 gene mutation in a large Pakistani family with Marfan syndrome. Mol Vis 2012;18:1918–1926
   PubMed Web of Science ®Google Scholar
• Ammash NM, Sundt TM, Connolly HM. Marfan syndrome-diagnosis and management. Curr Probl Cardiol 2008;33(1):7–39
   PubMed Web of Science ®Google Scholar
• Neptune ER, Frischmeyer PA, Arking DE, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003;33(3):407–411
   PubMed Web of Science ®Google Scholar
• Ades LC, Sullivan K, Biggin A, et al. FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited. American Journal of Medical Genetics 2006;140(10):1047–1058
   PubMedGoogle Scholar
• Robinson PN, Booms P, Katzke S, et al. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum Mutat 2002;20(3):153–161
   PubMed Web of Science ®Google Scholar
• Faivre L, Collod-Beroud G, Loeys BL, et al. Effect of mutation type and location on clinical outcome in 1013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. American Journal of Human Genetics 2007;81(3):454–466
   PubMed Web of Science ®Google Scholar
• Robinson PN, Arteaga-Solis E, Baldock C, et al. The molecular genetics of Marfan syndrome and related disorders. J Med Genet 2006;43(10):769–787
   PubMed Web of Science ®Google Scholar
• Rommel K, Karck M, Haverich A, et al. Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome. Hum Mutat 2005;26(6):529–539
   PubMed Web of Science ®Google Scholar
• Spaeth GL, Barber GW. Homocystinuria in a mentally retarded child and her normal cousin. Trans Am Acad Ophthalmol Otolaryngol 1965;69(5):912–930
   PubMedGoogle Scholar
• Gerritsen T, Waisman HA. Homocystinuria, an error in the metabolism of methionine. Pediatrics 1964;33:413–420
   PubMedGoogle Scholar
• Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. American Journal of Human Genetics 1985;37(1):1–31
   PubMed Web of Science ®Google Scholar
• Barber GW, Spaeth GL. The successful treatment of homocystinuria with pyridoxine. J Pediatr 1969;75(3):463–478
   PubMedGoogle Scholar
• Hubmacher D, Cirulis JT, Miao M, et al. Functional consequences of homocysteinylation of the elastic fiber proteins fibrillin-1 and tropoelastin. J Biol Chem 2010;285(2):1188–1198
   PubMedGoogle Scholar
• Whiteman P, Hutchinson S, Handford PA. Fibrillin-1 misfolding and disease. Antioxid Redox Signal 2006;8(3–4):338–346
   PubMedGoogle Scholar
• Martinez-Gutierrez JD, Mencia-Gutierrez E, Gracia-Garcia-Miguel T, et al. Classical familial homocystinuria in an adult presenting as an isolated lens subluxation. Int Ophthalmol 2011;31(3):227–232
   PubMedGoogle Scholar
• Skovby F, Gaustadnes M, Mudd SH. A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency. Mol Genet Metab 2010;99(1):1–3
   PubMed Web of Science ®Google Scholar
• Skovby F, Kraus JP, Rosenberg LE. Homocystinuria: biogenesis of cystathionine beta-synthase subunits in cultured fibroblasts and in an in vitro translation system programmed with fibroblast messenger RNA. American Journal of Human Genetics 1984;36(2):452–459
   PubMedGoogle Scholar
• Taoka S, Widjaja L, Banerjee R. Assignment of enzymatic functions to specific regions of the PLP-dependent heme protein cystathionine beta-synthase. Biochemistry 1999;38(40):13155–13161
   PubMedGoogle Scholar
• Munke M, Kraus JP, Ohura T, Francke U. The gene for cystathionine beta-synthase (CBS) maps to the subtelomeric region on human chromosome 21q and to proximal mouse chromosome 17. American Journal of Human Genetics 1988;42(4):550–559
   PubMedGoogle Scholar
• Kozich V, Sokolova J, Klatovska V, et al. Cystathionine beta-synthase mutations: effect of mutation topology on folding and activity. Hum Mutat 2010;31(7):809–819
   PubMedGoogle Scholar
• Sokolova J, Janosikova B, Terwilliger JD, et al. Cystathionine beta-synthase deficiency in Central Europe: discrepancy between biochemical and molecular genetic screening for homocystinuric alleles. Hum Mutat 2001;18(6):548–549
   PubMedGoogle Scholar
• Gallagher PM, Ward P, Tan S, et al. High frequency (71%) of cystathionine beta-synthase mutation G307S in Irish homocystinuria patients. Hum Mutat 1995;6(2):177–180
   PubMedGoogle Scholar
• Urreizti R, Asteggiano C, Bermudez M, et al. The p.T191M mutation of the CBS gene is highly prevalent among homocystinuric patients from Spain, Portugal and South America. J Hum Genet 2006;51(4):305–313
   PubMedGoogle Scholar
• De Lucca M, Casique L. Characterization of cystathionine beta-synthase gene mutations in homocystinuric Venezuelan patients: identification of one novel mutation in exon 6. Mol Genet Metab 2004;81(3):209–215
   PubMedGoogle Scholar
• Kruger WD, Wang L, Jhee KH, etal. Cystathionine beta-synthase deficiency in Georgia (USA): correlation of clinical and biochemical phenotype with genotype. Hum Mutat 2003;22(6):434–441
   PubMedGoogle Scholar
• Lee SJ, Lee DH, Yoo HW, et al. Identification and functional analysis of cystathionine beta-synthase gene mutations in patients with homocystinuria. J Hum Genet 2005;50(12):648–654
   PubMedGoogle Scholar
• Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program 2003:62–81
   PubMedGoogle Scholar
• Kim CE, Gallagher PM, Guttormsen AB, et al. Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet 1997;6(13):2213–2221
   PubMedGoogle Scholar
• Faivre L, Dollfus H, Lyonnet S, et al. Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome. American Journal of Medical Genetics 2003;123A(2):204–207
   PubMedGoogle Scholar
• Tsilou E, MacDonald IM. Weill-Marchesani Syndrome. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993--2013
   Google Scholar
• Hubmacher D, Apte SS. Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function. Cell Mol Life Sci 2011;68(19):3137–3148
   PubMedGoogle Scholar
• Kutz WE, Wang LW, Dagoneau N, et al. Functional analysis of an ADAMTS10 signal peptide mutation in Weill-Marchesani syndrome demonstrates a long-range effect on secretion of the full-length enzyme. Hum Mutat 2008;29(12):1425–1434
   PubMed Web of Science ®Google Scholar
• Evereklioglu C, Hepsen IF, Er H. Weill-Marchesani syndrome in three generations. Eye (Lond) 1999;13(Pt 6):773–777
   PubMedGoogle Scholar
• Wirtz MK, Samples JR, Kramer PL, et al. Weill-Marchesani syndrome: possible linkage of the autosomal dominant form to 15q21.1. Am J Med Genet 1996;65(1):68–75
   PubMedGoogle Scholar
• Kloepfer HW, Rosenthal JW. Possible genetic carriers in the spherophakia-brachymorphia syndrome. American Journal of Human Genetics 1955;7(4):398–425
   PubMedGoogle Scholar
• Faivre L, Megarbane A, Alswaid A, et al. Homozygosity mapping of a Weill-Marchesani syndrome locus to chromosome 19p13.3–p13.2. Hum Genet 2002;110(4):366–370
   PubMedGoogle Scholar
• Faivre L, Gorlin RJ, Wirtz MK, et al. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet 2003;40(1):34–36
   PubMed Web of Science ®Google Scholar
• Morales J, Al-Sharif L, Khalil DS, et al. Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. American Journal of Human Genetics 2009;85(5):558–568
   PubMedGoogle Scholar
• Kutz WE, Wang LW, Bader HL, et al. ADAMTS10 protein 780 interacts with fibrillin-1 and promotes its deposition in extracellular matrix of cultured fibroblasts. J Biol Chem 2011;286(19):17156–17167
   PubMed Web of Science ®Google Scholar
• Le Goff C, Morice-Picard F, Dagoneau N, et al. ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation. Nat Genet 2008;40(9):1119–1123
   PubMedGoogle Scholar
• Malfait F, Coucke P, Symoens S, et al. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients. Hum Mutat 2005;25(1):28–37
   PubMedGoogle Scholar
• Schalkwijk J, Zweers MC, Steijlen PM, et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 2001;345(16):1167–1175
   PubMed Web of Science ®Google Scholar
• Schwarze U, Hata R, McKusick VA, et al. Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. American Journal of Human Genetics 2004;74(5):917–930
   PubMedGoogle Scholar
• Makareeva E, Cabral WA, Marini JC, Leikin S. Molecular mechanism of alpha 1(I)-osteogenesis imperfecta/Ehlers-Danlos syndrome: unfolding of an N-anchor domain at the N-terminal end of the type I collagen triple helix. J Biol Chem 2006;281(10):6463–6470
   PubMedGoogle Scholar
• Colige A, Nuytinck L, Hausser I, et al. Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene. J Invest Dermatol 2004;123(4):656–663
   PubMedGoogle Scholar
• Woody NC. Hyperlysinemia. Am J Dis Child 1964;108:543–553
   PubMedGoogle Scholar
• Ozalp I, Hasanoglu A, Tuncbilek E, Yalaz K. Hyperlysinemia without clinical findings. Acta Paediatr Scand 1981;70(6):951–953
   PubMedGoogle Scholar
• Dancis J, Hutzler J, Cox RP, Woody NC. Familial hyperlysinemia with lysine-ketoglutarate reductase insufficiency. J Clin Invest 1969;48(8):1447–1452
   PubMedGoogle Scholar
• Bhattacharjee JK. alpha-Aminoadipate pathway for the biosynthesis of lysine in lower eukaryotes. Crit Rev Microbiol 1985;12(2):131–151
   PubMedGoogle Scholar
• Sacksteder KA, Biery BJ, Morrell JC, et al. Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia. American Journal of Human Genetics 2000;66(6):1736–1743
   PubMedGoogle Scholar
• Mudd SH, Irreverre F, Laster L. Sulfite oxidase deficiency in man: demonstration of the enzymatic defect. Science 1967;156(3782):1599–1602
   PubMedGoogle Scholar
• Tan WH, Eichler FS, Hoda S, et al. Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature. Pediatrics 2005;116(3):757–766
   PubMed Web of Science ®Google Scholar
• Dublin AB, Hald JK, Wootton-Gorges SL. Isolated sulfite oxidase deficiency: MR imaging features. AJNR Am J Neuroradiol 2002;23(3):484–485
   PubMedGoogle Scholar
• Schiaffino MC, Fantasia AR, Minniti G, et al. Isolated sulphite oxidase deficiency: clinical and biochemical features in an Italian patient. J Inherit Metab Dis 2004;27(1):101–102
   PubMedGoogle Scholar
• Sachdev NH, Coroneo MT, Wakefield D, Hennessy MP. Isolated ectopia lentis: potential role of matrix metalloproteinases in fibrillin degradation. Arch Ophthalmol 2004;122(1):111–114
   PubMedGoogle Scholar
• Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000;1477(1–2):267–283
   PubMed Web of Science ®Google Scholar
• Lee HF, Mak BS, Chi CS, et al. A novel mutation in neonatal isolated sulphite oxidase deficiency. Neuropediatrics 2002;33(4):174–179
   PubMedGoogle Scholar
• Johnson JL, Rajagopalan KV, Renier WO, et al. Isolated sulfite oxidase deficiency: mutation analysis and DNA-based prenatal diagnosis. Prenatal Diagnosis 2002;22(5):433–436
   PubMedGoogle Scholar
• Rupar CA, Gillett J, Gordon BA, et al. Isolated sulfite oxidase deficiency. Neuropediatrics 1996;27(6):299–304
   PubMedGoogle Scholar
• al-Salem M. Autosomal recessive ectopia lentis in two Arab family pedigrees. Ophthalmic Paediatr Genet 1990;11(2):123–127
   PubMed Web of Science ®Google Scholar
• Goldberg MF. Clinical manifestations of ectopia lentis et pupillae in 16 patients. Ophthalmology 1988;95(8):1080–1087
   PubMedGoogle Scholar
• Luebbers JA, Goldberg MF, Herbst R, et al. Iris transillumination and variable expression in ectopia lentis et pupillae. Am J Ophthalmol 1977;83(5):647–656
   PubMed Web of Science ®Google Scholar
• Kainulainen K, Karttunen L, Puhakka L, et al. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat Genet 1994;6(1):64–69
   PubMed Web of Science ®Google Scholar
• Lonnqvist L, Child A, Kainulainen K, et al. A novel mutation of the fibrillin gene causing ectopia lentis. Genomics 1994;19(3):573–576
   PubMed Web of Science ®Google Scholar
• Ades LC, Holman KJ, Brett MS, et al. Ectopia lentis phenotypes and the FBN1 gene. American Journal of Medical Genetics 2004;126A(3):284–289
   PubMedGoogle Scholar